Benzinga's Top #PreMarket Gainers

Exelixis, Inc. EXEL shares rose 53.45 percent to $6.00 in pre-market trading after the company reported positive top-line results from METEOR, Phase 3 pivotal trial of Cabozantinib vs. Everolimus in patients with metastatic renal cell carcinoma. Horizon Pharma PLC HZNP gained 6.53 percent to $39.50 in pre-market trading after the company issued a strong Q2 sales forecast. Halliburton Company HAL shares rose 3.25 percent to $41.29 in pre-market trading after the company reported stronger-than-expected results for its second quarter. Cellectis SA (ADR) CLLS shares climbed 3.07 percent to $41.00 in pre-market trading. Bank of America initiated coverage on Cellectis with a Buy rating and a $50.00 price target. Morgan Stanley MS shares climbed 3.03 percent to $41.42 in pre-market trading after the company reported upbeat earnings for the second quarter.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!